[1]曾令成,厉华,陈如东,等.偶发低级别胶质瘤的手术效果及生存预后的影响因素分析[J].中国临床神经外科杂志,2023,28(09):554-558562.[doi:10.13798/j.issn.1009-153X.2023.09.003]
 ZENG Ling-cheng,LI Hua,CHEN Ru-dong,et al.Surgical outcomes and survival analysis of patients with incidental low-grade gliomas[J].,2023,28(09):554-558562.[doi:10.13798/j.issn.1009-153X.2023.09.003]
点击复制

偶发低级别胶质瘤的手术效果及生存预后的影响因素分析()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年09期
页码:
554-558562
栏目:
论著
出版日期:
2023-09-30

文章信息/Info

Title:
Surgical outcomes and survival analysis of patients with incidental low-grade gliomas
文章编号:
1009-153X(2023)09-0554-05
作者:
曾令成厉华陈如东杨洪宽陈坚于加省
430030武汉,华中科技大学同济医学院附属同济医院神经外科(曾令成、厉华、陈如东、杨洪宽、陈坚、于加省)
Author(s):
ZENG Ling-cheng LI Hua CHEN Ru-dong YANG Hong-kuan CHEN Jian YU Jia-sheng
Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
关键词:
偶发低级别胶质瘤显微手术生存预后影响因素
Keywords:
Incidental low-grade gliomas Surgery Survival prognosis Influencing factors
分类号:
R 739.41; R 651.1+1
DOI:
10.13798/j.issn.1009-153X.2023.09.003
文献标志码:
A
摘要:
目的 探讨偶发低级别胶质瘤的手术效果及生存预后的影响因素。方法 回顾性分析2010年1月1日至2017年12月31日手术治疗的75例成人大脑半球偶发低级别胶质瘤的临床资料。结果 75例中,出现临床症状之前手术49例(无症状组),出现症状之后手术26例(症状组)。肿瘤全切除59例(78.7%),次全切除13例(17.3%),部分切除3例(4%);术后病理检查结果显示弥漫性星形细胞瘤44例(58.7%),少突胶质细胞瘤31例(41.3%)。症状组术后功能障碍发生率(11.5%,2/26)明显高于无症状组(0%;P<0.05)。59例(无症状组33例,症状组26例)术前接受MRI随访12~60个月,平均(30±10)个月;其中症状组术前随访18~60个月,平均(35±10)个月;无症状组术前随访12~38个月,平均(25±7)个月。59例肿瘤生长速率1~5 mm/年,平均(2.7±0.9)mm/年;无症状组生长速率1~5 mm/年,平均(2.9±0.9)mm/年;症状组生长速率1~4 mm/年,平均(2.5±0.7)mm/年;两组肿瘤生长速率无显著差别(P>0.05)。多因素Cox回归分析显示肿瘤切除程度、病理性质是病人总生存期(OS)、无症状生存期(PFS)及恶性进展期(MPFS)的独立影响因素,生存曲线分析显示肿瘤全切除病人的中位OS、PFS和MPFS均明显优于肿瘤未全切除病人(P<0.05),少突胶质细胞瘤病人的中位OS、PFS、MPFS均显著优于弥漫性星形细胞瘤病人(P<0.05)。结论 偶发低级别胶质瘤是一类恶性度较低、呈缓慢进展的疾病。肿瘤全切除有助于改善病人的生存预后,因此,手术时机的抉择应充分考虑利于肿瘤全切除,以延长病人生存期同时兼顾功能保护的目的。
Abstract:
Objective To investigate the surgical outcomes and prognostic factors of patients with incidental low-grade gliomas. Methods The clinical data of 75 patients with incidental low-grade gliomas treated surgically from January 1, 2010 to December 31, 2017 were retrospectively analyzed. Results Of these 75 patients, 49 patients received surgery before the onset of clinical symptoms (asymptomatic group), and 26 received surgery after the onset of clinical symptoms (symptomatic group). Total resection was achieved in 59 patients (78.7%), subtotal in 13 (17.3%), and partial in 3 (4%). Postoperative pathological examination showed diffuse astrocytoma in 44 patients (58.7%) and oligodendroglioma in 31 (41.3%). The incidence of postoperative dysfunction in the symptomatic group (11.5%, 2/26) was significantly higher than that (0%) in the asymptomatic group (P<0.05). Fifty-nine patients (33 patients in the asymptomatic group and 26 patients in the symptomatic group) were followed up by MRI for 12~60 months before surgery, with an average of (30±10) months. The preoperative follow-up period of the symptomatic group was 18~60 months, with an average of (35±10) months. The preoperative follow-up period of the asymptomatic group was 12~38 months, with an average of (25±7) months. The growth rate of the 59 patients was 1~5 mm/year, with an average of (2.7±0.9) mm/year. The growth rate of the asymptomatic group was 1~5 mm/year, with an average of (2.9±0.9) mm/year. The growth rate of the symptomatic group was 1~4 mm/year, with an average of (2.5±0.7) mm/year. There was no significant difference in the growth rate of the two groups (P>0.05). Multivariate Cox regression analysis showed that the extent of tumor resection and pathological nature were independent factors affecting overall survival (OS), progression-free survival (PFS) and malignant progression free survival (MPFS). Survival curve analysis showed that the median OS, PFS and MPFS of patients with total tumor resection were significantly better than those of patients with subtotal tumor resection (P<0.05), and the median OS, PFS and MPFS of patients with oligodendroglioma were significantly better than those of patients with diffuse astrocytoma (P<0.05). Conclusions Incidental low-grade gliomas is a kind of disease with low malignant degree and slow progression. Total tumor resection is helpful to improve the survival prognosis of patients. Therefore, the timing of surgery should be fully considered to be beneficial to total tumor resection, so as to prolong the survival of patients and protect function.

参考文献/References:

[1] ZHANG ZY, CHAN AK, NG HK, et al. Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis [J]. Int J Clin Exp Pathol, 2014, 7(12): 8627-8636.
[2] PALLUD J, FONTAINE D, DUFFAU H, et al. Natural history of incidental World Health Organization grade Ⅱ gliomas [J]. Ann Neurol, 2010, 68(5): 727-733.
[3] WIJNENGA MMJ, MATTNI T, FRENCH PJ, et al. Does early resection of presumed low-grade glioma improve survival: a clinical perspective[J]. J Neurooncol, 2017, 133(1): 137-146.
[4] RECHT LD, LEW R, SMITH T. Suspected low-grade glioma: is deferring treatment safe [J]? Ann Neurol, 1992, 31(4): 431-436.
[5] 张庆浩,段文超,刘献志,等. 无症状WHOⅡ级脑胶质瘤的疾病特征和术后生存分析[J]. 中华神经外科杂志, 2020, 36(4):405-409.
[6] POTTS MB, SMITH JS, MOLINARO AM, et al. Natural history and surgical management of incidentally discovered low-grade gliomas [J]. J Neurosurg, 2012, 116(2): 365-372.
[7] IUS T, CESSELLI D, ISOLA M, et al. Incidental low-grade gliomas: single-institution management based on clinical, surgical, and molecular data [J]. Neurosurgery, 2020, 86(3): 391-399.
[8] ALLISON C M, SHUMON S, STUMMER W, et al. A cohort analysis of truly incidental low-grade gliomas [J]. World Neurosurg, 2022, 159: e347-e355.
[9] OPOKU-DARKO M, EAGLES ME, CADIEUX M, et al. Natural history and growth patterns of incidentally discovered diffusely infiltrating low-grade gliomas: a volumetric study [J]. World Neurosurg, 2019, pii: S1878-8750.
[10] GUI C, KOSTENIUK SE, LAU JC, et al. Tumor growth dynamics in serially-imaged low-grade glioma patients [J]. J Neurooncol, 2018, 139(1): 167-175.
[11] GOGOS AZJ, YOUNG JS, PEREIRA MP, et al. Surgical management of incidentally discovered low-grade gliomas [J]. J Neurosurg, 2020, 135(2): 480-487.
[12] PALLUD J, CAPELLE L, TAILLANDIER L, et al. The silent phase of diffuse low-grade gliomas: is it when we missed the action [J]? Acta Neurochir (Wien), 2013, 155(12): 2237-2242.
[13] DUFFAU H. Awake surgery for incidental WHO grade Ⅱ gliomas involving eloquent areas [J]. Acta Neurochir (Wien), 2012, 154(4): 575-584.
[14] LIMA GLO, DEZAMIS E, CORNS R, et al. Surgical resection of incidental diffuse gliomas involving eloquent brain areas: rationale, functional, epileptological and oncological outcomes [J]. Neurochirurgie, 2017, 63(3): 250-258.
[15] NG S, HERBET G, MORITZ-GASSER S, et al. Return to work following surgery for incidental diffuse low-grade glioma: a prospective series with 74 patients [J]. Neurosurgery, 2020, 87(4): 720-729.
[16] COCHEREAU J, HERBET G, RIGAU V, et al. Acute progression of untreated incidental WHO Grade Ⅱ glioma to glioblastoma in an asymptomatic patient [J]. J Neurosurg, 2016, 124(1): 141-145.

相似文献/References:

[1]林国中 王振宇 马长城 赵 薇.神经电生理监测下显微手术切除脊髓髓内肿瘤[J].中国临床神经外科杂志,2015,(11):647.[doi:10.13798/j.issn.1009-153X.2015.11.003]
 LIN Guo-zhong,WANG Zhen-yu,MA Chang-cheng,et al.Clinical value of intraoperative electrophysiological monitoring to microsurgery for intramedullary spinal tumors[J].,2015,(09):647.[doi:10.13798/j.issn.1009-153X.2015.11.003]
[2]谢京城 王振宇 陈晓东.骶管终丝脊膜囊肿合并脊髓拴系综合征的诊断和治疗[J].中国临床神经外科杂志,2015,(11):651.[doi:10.13798/j.issn.1009-153X.2015.11.004]
 XIE Jing-cheng,WANG Zhen-yu,CHEN Xiao-dong.Diagnosis and surgical treatment of sacral spinal meningeal cysts of fila terminale complicated with tethered spinal cord syndrome[J].,2015,(09):651.[doi:10.13798/j.issn.1009-153X.2015.11.004]
[3]于 涛 黄正通 王振宇.椎管内脊膜囊肿的临床特征和治疗方法[J].中国临床神经外科杂志,2015,(11):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
 YU Tao,HUANG Zheng-tong,WANG Zhen-yu.Clinical features and treatment of intraspinal arachnoid cysts[J].,2015,(09):654.[doi:10.13798/j.issn.1009-153X.2015.11.005]
[4]谢宝树 王 宇 贾 锋 张 林 殷玉华.神经电生理监测下显微手术治疗成人脊髓栓系综合征[J].中国临床神经外科杂志,2015,(11):658.[doi:10.13798/j.issn.1009-153X.2015.11.006]
 XIE Bao-shu,WANG Yu,JIA Feng,et al.Intraoperative electrophysiological monitoring-guided microsurgery on tethered spinal cord syndrome in adults[J].,2015,(09):658.[doi:10.13798/j.issn.1009-153X.2015.11.006]
[5]赵东升 王正君 孙刚锋 费 舟 姬西团 李 娟 万晓强.椎管内畸胎瘤的诊断与治疗[J].中国临床神经外科杂志,2015,(11):661.[doi:10.13798/j.issn.1009-153X.2015.11.007]
 ZHAO Dong-sheng,WANG Zheng-jun,SUN Gang-feng,et al.Dignosis and treatment of intraspainal teratomas[J].,2015,(09):661.[doi:10.13798/j.issn.1009-153X.2015.11.007]
[6]陈晓东 于 涛 王振宇.脊髓髓内神经鞘瘤的诊断与治疗[J].中国临床神经外科杂志,2015,(11):670.[doi:10.13798/j.issn.1009-153X.2015.11.010]
 CHEN Xiao-dong,YU Tao,WANG Zhen-yu.Diagnosis and treatment of intramedullary spinal schwannomas[J].,2015,(09):670.[doi:10.13798/j.issn.1009-153X.2015.11.010]
[7]马 磊 张海红 张 威 衡立君 孙树凯 贾 栋.眶上锁孔入路手术切除前颅底脑膜瘤的临床效果[J].中国临床神经外科杂志,2015,(11):680.[doi:10.13798/j.issn.1009-153X.2015.11.013]
 MA Lei,ZHANG Hai-hong,ZHANG Wei,et al.Microsurgery through supraorbital keyhole approach for anterior cranial fossa meningiomas[J].,2015,(09):680.[doi:10.13798/j.issn.1009-153X.2015.11.013]
[8]李春坡 郑 军 李海元 边 涛 韩安国.侧脑室三角区小型脑膜瘤的显微外科治疗[J].中国临床神经外科杂志,2015,(11):694.[doi:10.13798/j.issn.1009-153X.2015.11.018]
[9]张兆斯 但 炜 王 刚 周 超 孙 超 谢延风 石全红 詹 彦.咪达唑仑和丙泊酚诱导麻醉对继发性癫痫术中皮层脑电图的影响[J].中国临床神经外科杂志,2016,(05):261.[doi:10.13798/j.issn.1009-153X.2016.05.002]
 ZHANG Zhao-si,DAN Wei,WANG Gang,et al.Effects of midazolam or propofol used for induction of anesthesia on intraoperative ECoG in patients with secondary epilepsy[J].,2016,(09):261.[doi:10.13798/j.issn.1009-153X.2016.05.002]
[10]赵 平 王雄伟 汪 雷 马金阳.显微手术和血管内栓塞术治疗颅内动脉瘤的疗效分析[J].中国临床神经外科杂志,2016,(05):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]
 ZHAO Ping,WANG Xiong-wei,WANG Lei,et al.Effect of endovascular treatment on intracranial aneurysms: a comparison with microsurgery[J].,2016,(09):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]

备注/Memo

备注/Memo:
(2023-05-06收稿,2023-07-31修回)
通讯作者:于加省,E-mail:yujiasheng2000@tjh.tjmu.edu.cn
更新日期/Last Update: 2022-09-30